Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eledon Pharmaceuticals Ord Shs (ELDN)  
$2.19 0.12 (5.19%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 14,310,000
Market Cap: 31.34(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.12 - $2.77
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eledon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing targeted medicines for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with amyotrophic lateral sclerosis. Co.'s lead compound in development is AT-1501, an IgG1, anti-CD40L antibody with high affinity for CD40 Ligand, a biological target. AT-1501 is engineered to improve safety and provide pharmacokinetic, pharmacodynamic and dosing advantages. By blocking CD40L and not the CD40 receptor, AT-1501 inhibits both the CD40 and CD11 costimulatory signaling pathways, providing the potential for improved efficacy compared to anti-CD40 receptor approaches.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,979,932
Total Buy Value $0 $0 $0 $2,597
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 89
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Novartis Ag 10% Owner   –       –       •   2015-07-15 4 S $14.26 $50,844 D/D (3,566) 4,493,458     -
   Novartis Ag 10% Owner   –       –       •   2015-07-14 4 S $14.41 $401,477 D/D (27,861) 4,497,024     -
   Novartis Ag 10% Owner   –       –       •   2015-07-13 4 S $14.20 $292,717 D/D (20,611) 4,524,885     -
   Morrison Jodie Pope President and CEO   •       •      –    2015-06-29 4 AS $13.70 $109,600 D/D (8,000) 9,551     -
   Morrison Jodie Pope President and CEO   •       •      –    2015-06-29 4 OE $1.58 $12,640 D/D 8,000 17,551     -
   Morrison Jodie Pope President and CEO   •       •      –    2015-06-26 4 AS $13.83 $110,640 D/D (8,000) 9,551     -
   Morrison Jodie Pope President and CEO   •       •      –    2015-06-26 4 OE $1.58 $12,640 D/D 8,000 17,551     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-24 4 AS $14.20 $4,260 D/D (300) 0     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-24 4 OE $4.19 $1,257 D/D 300 300     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-23 4 AS $14.00 $93,800 D/D (6,700) 0     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-23 4 OE $4.19 $28,073 D/D 6,700 6,700     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-22 4 AS $14.02 $28,040 D/D (2,000) 0     -
   Mcbride John S. Chief Operating Officer   •       –      –    2015-06-22 4 OE $4.19 $8,380 D/D 2,000 2,000     -
   Novartis Ag 10% Owner   –       –       •   2015-06-16 4 S $14.27 $15,982 D/D (1,120) 4,545,496     -
   Novartis Ag 10% Owner   –       –       •   2015-06-12 4 S $14.20 $84,050 D/D (5,919) 4,561,393     -
   Novartis Ag 10% Owner   –       –       •   2015-06-11 4 S $14.20 $395,825 D/D (27,875) 4,567,312     -
   Kalowski Lee Chief Financial Officer   •       –      –    2015-04-16 4 AS $13.00 $59,371 D/D (4,567) 47,779     -
   Kalowski Lee Chief Financial Officer   •       –      –    2015-04-02 4 AS $11.45 $25,854 D/D (2,258) 52,346     -
   Novartis Ag 10% Owner   –       –       •   2015-03-19 4 S $14.50 $669,045 D/D (46,141) 4,595,187     -
   Novartis Ag 10% Owner   –       –       •   2015-03-18 4 S $14.50 $43,500 D/D (3,000) 4,641,328     -
   Apple Tree Partners Iv, L.p. Director   –       •       •   2014-09-22 3 IO $0.00 $0 D/D 0 125,000     -
   Apple Tree Partners Ii - Annex, L.p. Director   –       •       •   2014-09-22 4 B $15.00 $3,562,500 D/D 237,500 3,568,438 3.92     -
   Apple Tree Partners Ii - Annex, L.p. Director   –       •       •   2014-09-22 4 A $0.00 $0 D/D 3,330,938 3,330,938     -
   Satter Muneer A 10% Owner   –       –       •   2014-09-22 4 B $15.00 $2,250,000 I/I 150,000 1,771,688 1.5     -
   Satter Muneer A 10% Owner   –       –       •   2014-09-22 4 A $0.00 $0 I/I 1,621,688 1,621,688     -
  89 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us